Neurogene Inc. SEC filings NGNE
Neurogene Inc. has 750 filings in SEC EDGAR's recent list, going back to Jun 25, 2007. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 2, 2026 | Jun 30, 2026 |
| 424B5 | Prospectus supplement | Jul 2, 2026 | — |
| 424B5 | Prospectus supplement | Jun 30, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 29, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 8, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 20, 2026 | Apr 20, 2026 |
| ARS | Annual report to shareholders | Apr 16, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| DEF 14A | Proxy statement | Apr 16, 2026 | Jun 3, 2026 |
| S-8 | Employee stock plan registration | Mar 24, 2026 | — |
| 10-K | Annual report | Mar 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2026 | Mar 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 9, 2025 | Oct 9, 2025 |
| 424B5 | Prospectus supplement | Aug 11, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Other events
|
Jun 9, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Results of operations
|
May 9, 2025 | May 9, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Apr 25, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 14, 2025 | Apr 14, 2025 |
| EFFECT | Filing | Apr 4, 2025 | — |
| CORRESP | Letter to the SEC | Apr 2, 2025 | — |
| 424B3 | Prospectus | Apr 1, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2025 | — |
| EFFECT | Filing | Mar 28, 2025 | — |
| S-3 | Shelf registration | Mar 24, 2025 | — |
| POS AM | Filing | Mar 24, 2025 | — |
| S-8 | Employee stock plan registration | Mar 24, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 24, 2025 | Mar 24, 2025 |
| 10-K | Annual report | Mar 24, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 424B3 | Prospectus | Dec 18, 2024 | — |
| EFFECT | Filing | Dec 16, 2024 | — |
| CORRESP | Letter to the SEC | Dec 12, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2024 | — |
| S-1 | Registration statement | Dec 2, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 21, 2024 | Nov 20, 2024 |
| 10-Q | Quarterly report | Nov 18, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 18, 2024 | Nov 18, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 18, 2024 | Nov 18, 2024 |
| NT 10-Q | Filing | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 12, 2024 | Nov 11, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Nov 4, 2024 | Nov 4, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2024 | Aug 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 21, 2024 | Jun 21, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 3, 2024 | Jun 3, 2024 |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 10, 2024 | May 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 7, 2024 | May 7, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Apr 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 25, 2024 | Apr 19, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 22, 2024 | Apr 22, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2024 | Mar 18, 2024 |
| 10-K | Annual report | Mar 18, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 21, 2024 | Feb 15, 2024 |
| S-8 | Employee stock plan registration | Feb 20, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Dec 19, 2023 | Dec 13, 2023 |
| 425 | Filing | Dec 6, 2023 | — |
| 8-K |
Current report
Other events
|
Dec 6, 2023 | Dec 6, 2023 |
| 425 | Filing | Dec 4, 2023 | — |
| 8-K |
Current report
Other events
|
Dec 4, 2023 | Nov 30, 2023 |
| 425 | Filing | Nov 30, 2023 | — |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| SEC STAFF LETTER | Filing | Nov 13, 2023 | — |
| EFFECT | Filing | Nov 13, 2023 | — |
| CORRESP | Letter to the SEC | Nov 8, 2023 | — |
| CORRESP | Letter to the SEC | Nov 8, 2023 | — |
| S-4/A | Filing | Nov 8, 2023 | — |
| CORRESP | Letter to the SEC | Oct 18, 2023 | — |
| S-4/A | Filing | Oct 18, 2023 | — |
| SEC STAFF LETTER | Filing | Oct 10, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 10, 2023 | — |
| 425 | Filing | Oct 5, 2023 | — |
| CORRESP | Letter to the SEC | Sep 28, 2023 | — |
| S-4/A | Filing | Sep 28, 2023 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Sep 22, 2023 | Sep 22, 2023 |
| UPLOAD | Letter from the SEC | Sep 18, 2023 | — |
| S-4 | Registration for a merger or exchange | Aug 21, 2023 | — |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 425 | Filing | Jul 18, 2023 | — |
| 425 | Filing | Jul 18, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Regulation FD disclosure
|
Jul 18, 2023 | Jul 17, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2023 | Jun 8, 2023 |
| 10-Q | Quarterly report | May 8, 2023 | Mar 31, 2023 |
| ARS | Annual report to shareholders | Apr 27, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2023 | — |
| DEF 14A | Proxy statement | Apr 27, 2023 | Jun 8, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 3, 2023 | Apr 3, 2023 |
| S-8 | Employee stock plan registration | Mar 21, 2023 | — |
| 10-K | Annual report | Mar 20, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change
|
Mar 10, 2023 | Mar 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 8, 2023 | Mar 8, 2023 |
| 8-K/A |
Amended current report
Bylaw or fiscal year change
|
Jan 23, 2023 | Nov 30, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 30, 2022 | Nov 30, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Listing notice
|
Oct 31, 2022 | Oct 26, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 27, 2022 | Jul 27, 2022 |
| EFFECT | Filing | May 18, 2022 | — |
| CORRESP | Letter to the SEC | May 16, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
May 16, 2022 | May 12, 2022 |
| UPLOAD | Letter from the SEC | May 13, 2022 | — |
| S-3 | Shelf registration | May 9, 2022 | — |
| 10-Q | Quarterly report | May 9, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| DEFA14A | Additional proxy material | Mar 31, 2022 | — |
| DEF 14A | Proxy statement | Mar 31, 2022 | May 12, 2022 |
| S-8 | Employee stock plan registration | Mar 1, 2022 | — |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Mar 1, 2022 | Feb 25, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 15, 2022 | Feb 14, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 19, 2021 | Nov 17, 2021 |
| 8-K |
Current report
Other events
|
Nov 16, 2021 | Nov 16, 2021 |
| 8-K |
Current report
Material agreement
|
Nov 4, 2021 | Nov 4, 2021 |
| 424B5 | Prospectus supplement | Nov 4, 2021 | — |
| 10-Q | Quarterly report | Nov 4, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 29, 2021 | Sep 29, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 2, 2021 | Jun 2, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 14, 2021 | May 13, 2021 |
| 10-Q | Quarterly report | May 12, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2021 | May 11, 2021 |
| DEFA14A | Additional proxy material | Mar 31, 2021 | — |
| DEF 14A | Proxy statement | Mar 31, 2021 | May 13, 2021 |
| S-8 | Employee stock plan registration | Mar 25, 2021 | — |
| 10-K | Annual report | Mar 25, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2021 | Mar 25, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2021 | Jan 11, 2021 |
| EFFECT | Filing | Dec 21, 2020 | — |
| CORRESP | Letter to the SEC | Dec 17, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 16, 2020 | — |
| S-3 | Shelf registration | Dec 11, 2020 | — |
| 8-K |
Current report
Material agreement
|
Dec 1, 2020 | Nov 25, 2020 |
| 10-Q | Quarterly report | Nov 9, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2020 | Nov 9, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 10, 2020 | Sep 6, 2020 |
| 10-Q | Quarterly report | Aug 12, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2020 | Aug 12, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 3, 2020 | Aug 3, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 2, 2020 | Jul 1, 2020 |
| 424B5 | Prospectus supplement | Jul 2, 2020 | — |
| 424B5 | Prospectus supplement | Jul 1, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Jun 1, 2020 | May 29, 2020 |
| 10-Q | Quarterly report | May 6, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 6, 2020 | May 6, 2020 |
| S-8 | Employee stock plan registration | May 6, 2020 | — |
| 8-K |
Current report
Shareholder vote results
|
May 6, 2020 | May 5, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 17, 2020 | Apr 15, 2020 |
| DEFA14A | Additional proxy material | Apr 16, 2020 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 13, 2020 | Apr 9, 2020 |
| DEFA14A | Additional proxy material | Mar 24, 2020 | — |
| DEF 14A | Proxy statement | Mar 24, 2020 | May 5, 2020 |
| 8-K |
Current report
Auditor change
|
Mar 20, 2020 | Mar 20, 2020 |
| S-8 | Employee stock plan registration | Mar 12, 2020 | — |
| 10-K | Annual report | Mar 12, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2020 | Mar 12, 2020 |
| 8-K |
Current report
Other events
|
Mar 10, 2020 | Mar 10, 2020 |
| 8-K |
Current report
Officer or director change
|
Feb 25, 2020 | Feb 25, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Material agreement
|
Dec 30, 2019 | Dec 23, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 19, 2019 | Dec 17, 2019 |
| 424B5 | Prospectus supplement | Dec 18, 2019 | — |
| 424B5 | Prospectus supplement | Dec 17, 2019 | — |
| 8-K/A | Amended current report | Dec 17, 2019 | Aug 8, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 5, 2019 | Dec 5, 2019 |
| S-8 | Employee stock plan registration | Nov 15, 2019 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Nov 14, 2019 | Nov 12, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2019 | Nov 13, 2019 |
| 10-Q | Quarterly report | Nov 13, 2019 | Sep 30, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NGNE (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1404644
- Former names
- Neoleukin Therapeutics, Inc. (until Dec 6, 2023); AQUINOX PHARMACEUTICALS, INC (until Aug 12, 2019); AQUINOX PHARMACEUTICALS (USA) INC (until Dec 24, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.